Hepatitis B virus infection and the dialysis patient

Seminars in Dialysis

Volumn 21, Issue 5, 2008, Pages 440-446

  Fabrizi, Fabrizio ^a,b   Messa, Piergiorgio ^a   Martin, Paul ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; CHRONIC KIDNEY FAILURE; HEPATITIS B; HUMAN; IMMUNOCOMPETENCE; IMMUNOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; VIRUS LOAD;

ANTIVIRAL AGENTS; HEPATITIS B; HUMANS; IMMUNOCOMPETENCE; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; VIRAL LOAD;

EID: 54749142825     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00437.x     Document Type: Article

References (52)

1. Lai CL, Ratziu V, Yuen MF, Poynard T : Viral hepatitis B. Lancet 362 : 2089, 2003
2. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ : National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 18 : 52 61, 2005
3. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, La Bracque J, Port FK, Young EW : Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOOPS. Kidney Int 63 : 2222 2229, 2003
4. Inoue K, Ogawa O, Yamada M, Watanabe T, Okamoto H, Yoshiba M : Possible association of vigorous hepatitis B virus replication with the development of fulminant hepatitis. J Gastroenterol 41 : 383 387, 2006
5. Kondili LA, Genovese D, Argentini C, Chionne P, Toscani P, Fabro R, Cocconi R, Rapicetta M : Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a haemodialysis center. Eur J Clin Microbiol Infect Dis 25 : 527 531, 2006
6. Covic A, Iancu L, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, Covic M : Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 14 : 40 45, 1999
7. Vladutiu D, Cosa A, Neamtu A, State D, Braila M, Gherman M, Petui IM, Dulau-Florea I : Infection with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? J Viral Hepatitis 7 : 313 319, 2000
8. Lewis-Ximenez LL, Oliveira JM, Mercadante LAC, De Castro L, Santa Catharina W, Stuver S, Yoshida CFT : Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron 87 : 19 26, 2001
9. Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, Almawi WY : Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control 32 : 493 495, 2004
10. Carrilho FJ, Moraes CR, Pinho JRR, Mello IMVGC, Bertolini DA, Lemos MF, Moreira RC, Bassit LC, Cardoso RA, Ribeiro-dos-Santos G, Da Silva LC : Hepatitis B virus infection in haemodialysis centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology. BMC Public Health 4 : 13 24, 2004
11. Boulaajaj K, Elomary Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N : Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca. Nephrol Ther 1 : 274 284, 2005
12. Chattopadhyay S, Rao S, Das BC, Singh NP, Kar P : Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India. Hemodial Int 9 : 362 366, 2005
13. Ferreira RC, Teles SA, Dias MA, Tavares VR, Silva SA, Gomes SA, Yishida CF, Martins RM : Hepatitis B virus profile in hemodialysis patients in Central Brazil: prevalence, risk factors, and genotypes. Mem Inst Oswaldo Cruz 101 : 689 692, 2006
14. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H : Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail 28 : 729 735, 2006
15. CDC : Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 50 (RR-5 1 41, 2001
16. Marcelli D, Stanhard D, Conte F, Held PJ, Locatelli F, Port FK : ESRD patients mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 50 : 1013 1018, 1996
17. Marzano A, Angelucci E, Andreone P, Brunetto M, Bruno R, Burra P, Caraceni P, Daniele B, Di Marco V, Fabrizi F, Fagiuoli S, Grossi P, Lampertico P, Meliconi R, Mangia A, Puoti M, Raimondo G, Smedile A, for the Italian Association for the Study of the Liver (AISF) : Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis 39 : 397 408, 2007
18. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredkie M, Boyle P : Cancer in patients on dialysis for end-stage renal disease: an international and collaborative study. Lancet 354 : 93 99, 1999
19. Josselson J, Kyser BA, Weir MR, Sadler JH : Hepatitis B surface antigenemia in a chronic hemodialysis program: lack of influence on morbidity and mortality. Am J Kidney Dis 6 : 456 461, 1987
20. Jha R, Kher BA, Naik S, Elhance R, Gupta A, Sharma RK : Hepatitis B-associated liver disease in dialysis patients: role of vaccination. J Nephrol 6 : 98 103, 1993
21. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y : Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 109 : 1295 1300, 1995
22. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH : Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 69 : 459 465, 1995
23. Fabrizi F, Lunghi G, Colucci P, Finazzi S, Ponticelli C, Locatelli F : Reduced aminotransferase activity in patients with chronic renal failure not requiring dialysis: Impact on the evaluation of viral hepatitis. Am J Kidney Dis 28 : 1009 1015, 2001
24. Espinosa E, Martin-Malo A, Alvarez de Lara MA, Soriano S, Alijama P : High ALT levels predict viremia in anti HCV positive HD patients if a modified normal range of ALT is supplied. Clin Nephrol 54 : 151 156, 2000
25. Fabrizi F, Mangano S, Alongi G, Bisegna S, Finazzi S, Lunghi G, Ponticelli C : Influence of HBV viremia upon aminotransferase activity in dialysis population. Int J Artif Organs 26 : 1048 1055, 2003
26. Fabrizi F, De Vecchi AF, Qureshi AR, Aucella F, Lunghi G, Bruchfeld A, Bisegna S, Mangano S, Limido A, Vigilante D, Forcella M, Delli Carri P, Martin P : Gammaglutamyltranspeptidase activity and viral hepatitis in dialysis patients. Int J Artif Organs 30 : 6 15, 2007
27. Fabrizi F, Lunghi G, Alongi G, Bisegna S, Campolo G, Mangano S, Limido A, Pagliari B, Tettamanzi F, Ponticelli C : Biological dynamics of hepatitis B virus load in dialysis population. Am J Kidney Dis 41 : 1278 1285, 2003
28. Moutinho RS, Perez RM, Median-Pestana JO, Figueredo MS, Koide S, Lopes Alberto F, Silva AEB, Ferraz MLG : Low HBV DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B. J Med Virol 78 : 1284 1288, 2006
29. Kohler H : Hepatitis B immunization in dialysis patients - is it worthwhile? Nephrol Dial Transplant 9 : 1719 1720, 1994
30. Salo JR, Salo AA, Fahlberg WJ, Ellzey JT : Hepatitis B surface antigen in peritoneal fluid of HBsAg carriers undergoing peritoneal dialysis. J Med Virol 6 : 29 35, 1980
31. Kroes ACM, van Bommel EFH, Niesters HGM, Weimar W : Hepatitis B viral DNA detectable in dialysate. Nephron 67 : 369, 1994 [Letter]
32. Moynot A, Lazizi Y, Dubeuil P, Buisson C, Pillot J : Nature of HBsAg ultrafiltrate of haemodialysed patients: presence of viral DNA. Nephrol Dial Transplant 49 : 88, 1988 [Letter]
33. De Jong GMT, De Bruin W, Verresen L, Moshage H, Desmyter J, Yap SH : High-flux membranes are not permeable to hepatitis B virus DNA. Nephron 60 : 368, 1992 [Letter]
34. Rostaing L, Chatelut E, Payen JL, Izopet J, Thalamas C, Ton-That H, Pascal JP, Durand D, Canal P : Pharmacokinetics of alpha-2b in chronic hepatitis C undergoing chronic hemodialysis or with normal renal function: clinical implications. J Am Soc Nephrol 9 : 2344 2348, 1998
35. Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, Salvadori M, Como G, Ponticelli C, Graziani G : Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus positive patients only coincidental phenomena? Am J Kidney Dis 42 : 143 150, 2003
36. Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palu G, Reiss P, Thiebaut R, Weiland O, Yazdanpanah Y, Zeuzem S, ECC Jury : Short statement of the first European Consensus Conference on the treatment of chronic hepatitis C and B in HIV co-infected patients. J Hepatol 42 : 615 624, 2005
37. Locarnini S, Hatzakis A, Heathcote J, Keefe EB, Liang TJ, Mutimer D, Pawlotsky JM, Zoulim F : Management of antiviral resistance in patients with chronic hepatitis B. Antiviral Ther 9 : 679 683, 2004
38. Lok ASF : Navigating the maze of hepatitis B treatments. Gastroenterology 132 : 1586 1594, 2007
39. Duarte R, Huraib S, Said R, Abdel-Khadir A, Sullivan S, Chaballout A, Sbeih F, Hughal T : Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis. Am J Kidney Dis 25 : 40 45, 1995
40. Giorgianni V, Gattarello G, Cannata L : Trattamento con interferone alfa in pazienti emodializzati cronici con epatite cronica. Giorn It Nefrol 9 : 221 222, 1992
41. Tillmann HL, Wedmeyer H, Manns PM : Treatment of hepatitis B in special patient groups: hemodialysis, heart and renal transplant, fulminant hepatitis, hepatitis B virus reactivation. J Hepatol 39 : S206 S211, 2003
42. Fontaine H, Thiers V, Chretien Y, Zylberberg H, Poupon RE, Brechot C, Legendre C, Kreis H, Pol S : HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. Transplantation 69 : 2090 2094, 2000
43. Ben-Ari Z, Broida E, Kittai Y, Chagnac A, Tur-Kaspa R : An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation. Am J Gastroenterol 95 : 3579 3583, 2000
44. Boyacioglu S, Gur G, Gursoy M, Ozdemir N : Lamivudine in renal transplant candidates with chronic hepatitis B infection. Transplant Proc 34 : 2131 2132, 2002
45. Schmilovitz-Weiss H, Melzer E, Tu-Kaspa R, Ben-Ari Z : Excellent outcome of lamivudine treatment in patients with chronic renal failure and hepatitis B virus infection. J Clin Gastroenterol 37 : 64 67, 2003
46. Lapinski TW, Flisiak R, Jaroszewicz J, Michalewicz M, Kowalczuc O : Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation. World J Gastroenterol 11 : 400 402, 2005
47. Fontaine H, Vallet-Pichard A, Chaix ML, Currie G, Serpaggi J, Verkarre V, Varaut A, Morales E, Nalpas B, Bosgart C, Pol S : Efficacy and safery of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency. Transplantation 80 : 1086 1092, 2005
48. Tillmann HL, Bock CT, Black JS, Rosenau J, Baker KH, Bong-Hock H, Becker T, Trautwein C, Klenpnauer J, Flemming P, Manns P : Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency. Liver Transpl 9 : 191 196, 2003
49. Chan TM, Fang CX, Tang CSO, Cheng IKP, Lai KN, Ho SKN : Pre-emptive lamivudine therapy based on HBV DNA level in HBsAg positive kidney allograft recipients. Hepatology 36 : 1246 1252, 2002
50. Dulai G, Higa L, Kobashigawa J, Martin P : Successful use of lamivudine of severe acute hepatitis B virus infection in a cardiac transplant recipient. Transplantation 67 : 1288 1289, 1999 [Letter]
51. Thanachartwet V, Phumratanapaprin W, Desakorn V, Sahassananda D, Wattanagoon Y, Chaiprasert A, Aimpun P, Supaporn T : Viral hepatitis infections among dialysis patients: Thailand registry report. Nephrology 12 : 399 405, 2007
52. Qadi A, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, Almawi WY : Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control 32 : 493 495, 2004